• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROCATHETER SEQURE 28 130 X1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROCATHETER SEQURE 28 130 X1 Back to Search Results
Model Number SQ28_LB_130
Device Problem Flushing Problem (1252)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
As this case was related to user error, there is no plan to perform an investigation on the device.
 
Event Description
This incident was reported by a facility in (b)(6) on (b)(6) 2020 without sufficient information to process an mdr.Follow-up information, sufficient for processing, was received from reporter on 14 january 2021.Reporter states that the sequre catheter was used for angiomyolipoma embolization.Embolization was done with two types of agents: 700 um microspheres for a 2ml in 20ml dilution.A berenshtein liquid coil was added subsequently.The coil remained blocked in the sequre.The interventional radiologist was unable to flush the sequre.The radiologist then changed the microcatheter to complete the embolization, stating that there was no injury to the patient.
 
Event Description
This incident was reported by a facility in marseille, france on (b)(6) 2020 without sufficient information to process an mdr.Follow-up information, sufficient for processing, was received from reporter on (b)(6) 2021.This supplemental report is to document the change in reportability, to non-reportable.On (b)(6) 2020 a guerbet commercial engineer (ce) notified to the quality department by email a complaint regarding one sequre catheter clogging at chu marseille 13000 marseille.The ce was initially informed on (b)(6) 2020.The catheter was used for angiomyolipoma embolization.Embolization was done with two types of agents: 700m microspheres for a 2ml in 20ml dilution.A berenshtein liquid coil was added subsequently.The coil remained blocked in the sequre.The interventional radiologist was unable to flush the sequre.Additional information were requested to our ic (serial number, diameter of the sequre catheter, size of coils, details on the procedure, possible catheter replacement, procedure completed, consequences for the patient, etc.).
 
Manufacturer Narrative
Manufacturer: new information that was received indicating what type of coil was used : flushable coils, spif 2.5mm x10cm from balt, which is a 0.010" coil, and therefore off label for our microcatheters, as they are compatible only with 0.018" coils.As this was a user-error/deviation from label use, this incident was investigated at the manufacturer site, potential risk to the patient was assessed minor (via product risk analysis), and assessment has been changed to non-reportable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MICROCATHETER SEQURE 28 130 X1
Type of Device
MICROCATHETER SEQURE 28 130 X1
MDR Report Key11197984
MDR Text Key244239035
Report Number3011890588-2021-00001
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
PMA/PMN Number
K173430
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/19/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSQ28_LB_130
Date Manufacturer Received01/14/2021
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-